دورية أكاديمية
Phase II Study of Eribulin plus Pembrolizumab in Metastatic Soft-tissue Sarcomas: Clinical Outcomes and Biological Correlates.
| العنوان: | Phase II Study of Eribulin plus Pembrolizumab in Metastatic Soft-tissue Sarcomas: Clinical Outcomes and Biological Correlates. |
|---|---|
| المؤلفون: | Haddox, Candace L, Nathenson, Michael J, Mazzola, Emanuele, Lin, Jia-Ren, Baginska, Joanna, Nau, Allison, Weirather, Jason L, Choy, Edwin, Marino-Enriquez, Adrian, Morgan, Jeffrey A, Cote, Gregory M, Merriam, Priscilla, Wagner, Andrew J, Sorger, Peter K, Santagata, Sandro, George, Suzanne |
| المصدر: | Clin Cancer Res ; ISSN:1557-3265 ; Volume:30 ; Issue:7 |
| بيانات النشر: | Silverchair Information Systems |
| سنة النشر: | 2024 |
| المجموعة: | PubMed Central (PMC) |
| الوصف: | Eribulin modulates the tumor-immune microenvironment via cGAS-STING signaling in preclinical models. This non-randomized phase II trial evaluated the combination of eribulin and pembrolizumab in patients with soft-tissue sarcomas (STS). |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| العلاقة: | https://doi.org/10.1158/1078-0432.CCR-23-2250Test; https://pubmed.ncbi.nlm.nih.gov/38236580Test; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10982640Test/ |
| DOI: | 10.1158/1078-0432.CCR-23-2250 |
| الإتاحة: | https://doi.org/10.1158/1078-0432.CCR-23-2250Test https://pubmed.ncbi.nlm.nih.gov/38236580Test https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10982640Test/ |
| حقوق: | ©2024 The Authors; Published by the American Association for Cancer Research. |
| رقم الانضمام: | edsbas.1D60E864 |
| قاعدة البيانات: | BASE |
| DOI: | 10.1158/1078-0432.CCR-23-2250 |
|---|